Phase I/II Clinical Trial of LBL-015 for Injection

Clinical trial NCT05107011 · COMPLETED

Trial details

NCT number: NCT05107011
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2021-11-08
Primary completion: 2023-12-05
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.